(Q48021487)

English

Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants

scientific article published on 6 December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Plasmodium falciparum

0 references

Escherichia coli

1 reference

based on heuristic

inferred from title

4

object named as

Brendan S Crabb

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Virander S Chauhan

7

object named as

Virander S Chauhan

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

author name string

Suraksha Sachdeva

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Asif Mohmmed

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Palakodeti V N Dasaradhi

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Anju Katyal

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Pawan Malhotra

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

language of work or name

0 references

publication date

6 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

24

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

12

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

2007-2016

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Merozoite antigens involved in invasion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Research toward vaccines against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Protective antigens of rodent and human bloodstage malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Merozoite surface antigen-I of plasmodium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Disulfide bonds in merozoite surface protein 1 of the malaria parasite impede efficient antigen processing and affect the in vivo antibody response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Expression and purification of Plasmodium falciparum MSP-1(42): A malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Deletion of Plasmodium berghei-specific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

The immune response to asexual blood stages of malaria parasites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

A robust neutralization test for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

A malaria merozoite surface protein (MSP1)-structure, processing and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.041

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.11.041

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16377036

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48021487&oldid=2181730108"